Amplitude Surgical
ISIN: FR0012789667 | Ticker: AMPLI | LEI: 9695006Q1VL1OHK06336
Country: France
Amplitude Surgical, which was founded in 1997, is a leading French player on the global surgical technology market for lower-limb orthopedics. Today, our products are used in over 400 healthcare facilities in France, and we have sold over 180,000 implants and prostheses worldwide in the past three years, including more than 70,000 in FY 2018 alone.
We are pressing ahead with our strategy of expansion predicated on our cutting-edge R&D, robust quality system, substantial investments and workforce of close to 420 highly motivated employees. Our goal is to tap into new markets while bringing to market innovative new devices and equipment benefiting practitioners and their patients.
1997
Served areaWorldwide
Headquarters11 Cours Jacques Offenbach, 26000 Valence – France
| Line item in (eur) | 01.07.2020 | 01.07.2021 | 01.07.2022 |
|---|---|---|---|
| Assets | N/A | 269,072,000.00 | 259,462,000.00 |
| Noncurrent Assets | N/A | 174,644,000.00 | 162,807,000.00 |
| Property Plant And Equipment | N/A | 42,208,000.00 | 33,528,000.00 |
| Goodwill | N/A | 95,670,000.00 | 95,719,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 29,238,000.00 | 28,003,000.00 |
| Deferred Tax Assets | N/A | 6,962,000.00 | 5,090,000.00 |
| Other Noncurrent Financial Assets | N/A | 567,000.00 | 468,000.00 |
| Current Assets | N/A | 94,428,000.00 | 96,655,000.00 |
| Inventories | N/A | 44,516,000.00 | 32,900,000.00 |
| Trade And Other Current Receivables | N/A | 16,987,000.00 | 17,801,000.00 |
| Current Tax Assets Current | N/A | 2,072,000.00 | 1,321,000.00 |
| Cash and cash equivalents | N/A | 30,675,000.00 | 21,043,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | 179,000.00 | 23,591,000.00 |
| Equity And Liabilities | N/A | 269,072,000.00 | 259,462,000.00 |
| Equity | 70,913,000.00 | 56,866,000.00 | 52,568,000.00 |
| Issued Capital | N/A | 478,000.00 | 480,000.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | -14,099,000.00 | -4,392,000.00 |
| Retained Earnings Excluding Profit Loss For Reporting Period | N/A | -74,662,000.00 | -88,067,000.00 |
| Share Premium | N/A | 146,677,000.00 | 146,675,000.00 |
| Noncontrolling Interests | N/A | -2,053,000.00 | -1,610,000.00 |
| Noncurrent Liabilities | N/A | 173,824,000.00 | 163,060,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 1,063,000.00 | 570,000.00 |
| Other Longterm Provisions | N/A | 14,074,000.00 | 16,088,000.00 |
| Deferred Tax Liabilities | N/A | 2,084,000.00 | 1,697,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 83,000.00 | 37,000.00 |
| Other Noncurrent Liabilities | N/A | 18,777,000.00 | 17,332,000.00 |
| Current Liabilities | N/A | 38,383,000.00 | 43,834,000.00 |
| Current Provisions | N/A | 134,000.00 | 244,000.00 |
| Trade And Other Current Payables | N/A | 26,814,000.00 | 22,693,000.00 |
| Current Tax Liabilities Current | N/A | 342,000.00 | 428,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 2,059,000.00 | 8,721,000.00 |
| Line item in (eur) | 01.07.2020/ 01.07.2021 |
01.07.2021/ 01.07.2022 |
|---|---|---|
| Revenue From Contracts With Customers | 82,713,000.00 | 87,559,000.00 |
| Other Work Performed By Entity And Capitalised | 3,775,000.00 | -202,000.00 |
| Raw Materials And Consumables Used | 14,040,000.00 | 12,649,000.00 |
| Cost Of Merchandise Sold | 8,118,000.00 | 7,095,000.00 |
| Services Expense | 23,786,000.00 | 24,255,000.00 |
| Employee Benefits Expense | 23,503,000.00 | 23,297,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | 0.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 0.00 | 0.00 |
| Tax Expense Other Than Income Tax Expense | 896,000.00 | 715,000.00 |
| Profit Loss From Operating Activities | -1,653,000.00 | 4,942,000.00 |
| Finance Income | 160,000.00 | 3,949,000.00 |
| Finance Costs | 10,251,000.00 | 10,524,000.00 |
| Income Tax Expense Continuing Operations | 1,927,000.00 | 1,190,000.00 |
| Profit Loss From Discontinued Operations | -996,000.00 | -1,972,000.00 |
| Profit (loss) | -14,667,000.00 | -4,794,000.00 |
| Profit Loss Attributable To Owners Of Parent | -14,099,000.00 | -4,392,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | -568,000.00 | -403,000.00 |
| Line item in (eur) | 01.07.2021 | 01.07.2022 |
|---|---|---|
| Profit (loss) | -14,667,000.00 | -4,794,000.00 |
| Adjustments For Income Tax Expense | 1,859,000.00 | 1,039,000.00 |
| Adjustments For Decrease Increase In Inventories | -2,910,000.00 | 2,947,000.00 |
| Adjustments For Sharebased Payments | 139,000.00 | 0.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 393,000.00 | -3,673,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 547,000.00 | 803,000.00 |
| Cash Flows From Used In Operating Activities | 2,344,000.00 | 7,983,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 5,136,000.00 | 5,192,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | 4,311,000.00 | 6,950,000.00 |
| Cash Flows From Used In Investing Activities | -9,164,000.00 | -12,412,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 105,741,000.00 | 2,029,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 102,802,000.00 | 7,887,000.00 |
| Cash Flows From Used In Financing Activities | 736,000.00 | -5,409,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -6,084,000.00 | -9,837,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 92,000.00 | 203,000.00 |
| Cash and cash equivalents | 30,675,000.00 | 21,043,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 01.02.24 | None | Other | Sell | EUR 174,150.00 |
FR0012789667
LEI9695006Q1VL1OHK06336
SectorHealth Care Equipment & Services
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.